Moximed
-
New funding fuels device-maker’s pursuit of FDA approval
Moximed snagged $40 million as it works to secure approval for its device, an implantable shock absorber for the knee designed to put off the need for full joint replacement. CEO Anton Clifford touts that the MISHA Knee System is the first of its kind.
-
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
-
Devices & Diagnostics, Startups
Starting your medical device startup in Europe? Consider 4 tips from CEOs who’ve been there, done that
What with the medical device tax and regulatory hurdles, there is a lot of medical […]
-
Devices & Diagnostics, Startups
Shock absorbers for the human body? Implant could help active patients avoid total knee replacements longer
Think shock absorbers for the human body. Moximed could help active and young patients who […]
Promoted
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients – all while using fewer staff resources.
Promoted
Payer’s Place: Dr. Anil Singh
Dr. Anil Singh shares his insights into the strategies employed by the organization to identify the most effective digital solutions for their members.
